Cargando…

A family cluster of diagnosed coronavirus disease 2019 (COVID‐19) kidney transplant recipient in Thailand

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes an ongoing outbreak of respiratory illness called coronavirus disease 2019 (COVID‐19). The clinical course could be ranging from mild to severe illness especially the individuals with an immunocompromised condition suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakulkonkij, Parichart, Bruminhent, Jackrapong, Pankongngam, Charan, Chalermphunchai, Nipon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436537/ https://www.ncbi.nlm.nih.gov/pubmed/32770646 http://dx.doi.org/10.1002/iid3.337

Ejemplares similares

Clinical outcome of rapid diagnosis and antibiotic stewardship in patients with bloodstream infection in Lampang Hospital
por: Sakulkonkij, Parichart, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
por: Sripongpun, Pimsiri, et al.
Publicado: (2022)

Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand
por: Bruminhent, Jackrapong, et al.
Publicado: (2020)

A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

1749. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1743. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality within the First Year after Kidney Transplantation: An Analysis of the National Transplant Registry
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Impact of Carbapenem Peri-Transplant Prophylaxis and Risk of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Early Urinary Tract Infection in Kidney Transplant Recipients: A Propensity Score-Matched Analysis
por: Aramwittayanukul, Suwadee, et al.
Publicado: (2022)

Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
por: Zhang, Hui, et al.
Publicado: (2020)

509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation
por: Namsiripongpan, Warunyu, et al.
Publicado: (2022)

Feature Importance of Acute Rejection among Black Kidney Transplant Recipients by Utilizing Random Forest Analysis: An Analysis of the UNOS Database
por: Thongprayoon, Charat, et al.
Publicado: (2021)

A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China
por: Chen, Song, et al.
Publicado: (2020)

1189. Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
por: Siripoon, Tanaya, et al.
Publicado: (2020)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

168. Epidemiology, Risk Factors and Outcome of Bloodstream Infection Within the First Year After Kidney Transplantation
por: Siritip, Napadol, et al.
Publicado: (2019)

Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Risk of Severe Coronavirus Disease 2019 Infection in Kidney Transplant Recipients
por: Sacristán, Pilar Galindo, et al.
Publicado: (2022)

494. Real-world effectiveness of tixagevimab/cilgavimab for COVID-19 pre-exposure prophylaxis in solid organ transplant recipients during the Omicron variant period
por: Rojanakit, Gun, et al.
Publicado: (2023)

Clinical and immunological characteristics for BK polyomavirus‐associated nephropathy after kidney transplantation
por: Siripoon, Tanaya, et al.
Publicado: (2023)

Telemedicine in the Care of Kidney Transplant Recipients With Coronavirus Disease 2019: Case Reports
por: Abuzeineh, Mohammad, et al.
Publicado: (2020)

Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience
por: Alkadi, Mohamad M., et al.
Publicado: (2021)

High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study
por: Requião-Moura, Lúcio R., et al.
Publicado: (2021)

Coronavirus Disease 2019 in Lung Transplant Recipients
por: Gergen, Anna K., et al.
Publicado: (2021)

2126. Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures
por: Sakulkonkij, Parichart, et al.
Publicado: (2019)

Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
por: Hayuk, Pattorn, et al.
Publicado: (2022)

Lung Transplantation for Coronavirus Disease-2019 Patients and Coronavirus Disease-2019 in Lung Transplant Recipients
por: Avella, Diego, et al.
Publicado: (2023)

A Kidney Transplant Recipient With Coronavirus Disease 2019: Utility of a Prognostication Score
por: Adrogué, A.H., et al.
Publicado: (2020)

Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis
por: Ho, Quan Yao, et al.
Publicado: (2021)

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients
por: Kute, Vivek, et al.
Publicado: (2022)

2508. Absolute Lymphocyte Count and Adenovirus-Specific CD8+ T-cell Immunity as Immunological Predictors of Severe Adenovirus Disease After Kidney Transplantation
por: Bruminhent, Jackrapong, et al.
Publicado: (2018)

Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study
por: Hardesty, Anna, et al.
Publicado: (2021)

Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience
por: Lum, Erik, et al.
Publicado: (2020)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

Clinical outcomes of coronavirus disease 2019 in liver transplant recipients
por: Shafiq, Muhammad, et al.
Publicado: (2022)

Hospital-at-home as a first-line strategy for kidney transplant recipients with coronavirus disease 2019 infection
por: Chang, Zi Yun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igjcthsvn2alu518h898pqfidn